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Abstract. We report the first case of multiple brain abscesses caused by Nocardia paucivorans in 
a patient suffering from multiple myeloma on treatment with lenalidomide and dexamethasone. 
N. paucivorans is a recently described species of the genus Nocardia, which is supposed to have a 
heightened neurotropism in cases of disseminated infection. Although nocardiosis itself is an 
uncommon infectious complication in multiple myeloma so far, nocardial brain abscess should 
be added to the spectrum of adverse effects due to this novel chemotherapy regimen.  
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Case Presentation. A 70-year-old male was 
transferred to our unit from the intensive care unit of a 
nearby hospital. He had had  sudden onset  clonic 
seizures involving the right hemisoma and the 
assessment of multiple brain abscesses by 
computerized tomography (CT) scan. The patient was 
receiving empirical treatment with metronidazole and 
cefotaxime. His past medical history included a 2-year-
history of IgA myeloma (International Staging System 
– II). The patient was initially treated with melphalan 
plus prednisone plus bortezomib (4 cycles) according 
to MPV protocol. Then, he started treatment with 
lenalidomide and dexamethasone having completed 
eleven cycles of such regimen with partial response. 
During the chemotherapy regimen the patient did not 
receive a trimethoprim-sulfamethoxazole (TMP-SMX) 
prophylaxis and, at time of admission, we discontinued 
the chemotherapy regimen for myeloma. The patient 
suffered from a 2-month history of subcutaneous 
abscess of unknown origin on the left shoulder. The 
lesion was drained, and  the microbiological analysis 
was not conclusive because of mixed bacterial flora. 
The patient was living in a small rural hamlet. He was  
 
a construction worker, but he retired 10 years before 
the present hospital admission.  
At hospital presentation, body temperature was 
36.5 °C, heart rate was 92/min, blood pressure was 
150/90 mmHg and Glasgow Coma Scale was 15/15. 
The patient was alert, oriented and no abnormal 
physical findings were shown, except for a painful 
hypoesthesia in the lateral and anterior sides of the left 
thigh, in the lateral side of the left leg and, on the 
dorsal side of the left foot. The subcutaneous abscess 
on the left shoulder  completely resolved  with no signs 
of local inflammation. Laboratory showed the 
following abnormalities: serum C-reactive protein 
96.19 nmol/L (normal values inferior to 71.43 nmol/L), 
hemoglobin 90 g/L, white blood cells 3.9 x 10
9
/L (51% 
neutrophil granulocytes). In addition, the analysis of 
peripheral blood lymphocytes subsets showed CD3+ 
742 cells/µL, CD3+CD4+ 420 cells/µL (47%), 
CD3+CD8+ 241 cells/µL (27%), CD4+/CD8+ ratio 
1.70, CD19+ 72 cells/µL.  Serum protein 
electrophoresis showed a relative hypoalbuminemia 
(55.4%) according to the known monoclonal 
gammopathy (serum IgA 4490 mg/L, monoclonal 
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component 3 g/L). The chest X-ray revealed a lower 
right lobe infiltrate associated with bilateral pleural 
effusion. A brain CT scan (Figure 1) with contrast 
medium showed 6 focal ring-enhancing lesions of 
which the largest one had a maximum diameter of 16 
mm (left occipital lobe). All the lesions had a minimal 
perilesional oedema. The right frontal lesions led to a 
mass effect on the right lateral ventricle. At that time, 
the patient underwent CT-guided brain biopsy of a 
parietal lesion. A bioptic sample revealed branching 
Gram positive nocardioform rods. Then, cultures were 
incubated aerobically at 35°C for three weeks. All 
whitish, chalky and wet hay-smelling colonies (Figure 
2) yielded on blood agar were stained by partial acid-
fast method according to Kinyoun technique modified 
for nocardioforms (Figure 3).  
  The suspicion that this  strain could belong to   
Actinomycetales genus was based on its failure to clear 
casein (Biorad, France), on the resistance to lysozime 
and 5-fluorouracil, and on the enzymatic profile, by the 
API ZYM system (bioMérieux, France).
1-2
 
Identification was completed by the evaluation of the 
absence of urease after growth on Christensen urea 
agar and incubation at 25°C for three weeks and of the 
incapacity to clear casein (Biorad, France).  Finally, 
genotypical identification has been performed by 
amplification and sequencing of a DNA fragment 
coding a rRNA 16S according with the manufacturer’s 
(Applied Biosystem, USA)  
 
 
Figure 1. Axial brain CT scan post-contrast medium 
administration. Images obtained before therapy show two ring-
enhancing lesions with abundant peripheral oedema in right parietal 
lobe (a) and one in left parietal lobe at the vertex (b). Images 
obtained after therapy (c,d) show the complete resolution of the 
lesions. 
 
Figure 2. Whitish chalky colonies of N. paucivorans yielded on 
blood agar. 
 
Figure 3. N. paucivorans hyphae. Staining by partial acid-fast 
method according to Kinyoun technique modified for 
nocardioforms. The vegetative hyphae are well developed with 
irregular branches. 
suggestions. Sequences have been compared with the 
reference ones present in the Gen Bank (NCB) 
database by the BLAST program. The sequence has 
been deposited in the GenBank (accession number: 
AY262324.1). Sequences producing significant 
alignments permitted to identify the strains as N. 
paucivorans with 100% value of identity with the 
reference strain.   
Minimal Inhibitory Concentrations' (MIC) testing 
was performed by the Epsilometer (E test, bioMérieux, 
France) testing. MICs' results were the following: 
amikacin 0.064 µg/mL, amoxicillin plus clavulanic 
acid (>256 µg/mL), ceftriaxone (0.75 µg/mL), 
cefepime (6 µg/mL), ciprofloxacin (0.047 µg/mL), 
clarithromycin (1 µg/mL), gentamicin (8 µg/mL), 
imipenem (0.19 µg/mL), linezolid (0.125 µg/mL), 
tobramycin (0.047 µg/mL), trimethoprim plus 
sulfonamide (0.002 µg/mL). Susceptibility testing was 
performed on Mueller Hinton Agar (bioMérieux). The 
results were read after 24 h of incubation at 37°C. 
Susceptibility testing was revised and interpreted 
according to CLSI criteria.
3
 In order to exclude 
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concomitant pulmonary nocardiosis, a diagnostic 
bronchoscopy was done but the microbiological 
analysis of the bronchoalveolar lavage isolated only 
commensal microbial flora. As a matter of fact, based 
on the initial identification and the preliminary 
antimicrobial susceptibility testing, intravenous TMP-
SMX plus meropenem were administered for 24 days. 
Such antibiotic regimen was switched to oral 
ciprofloxacin for an overall treatment period of 12 
months. The patient is doing well, his painful 
hypoesthesias have disappeared; no more seizure 
episodes and adverse effects due to long term antibiotic 
therapy occurred. The brain CT-scan monitoring 
showed a progressive reduction of all cerebral lesions 
(Figure 1).  
 
Discussion. Nocardia (order Actinomycetales) is a 
complex genus of Gram-positive and partially acid- 
and alcohol-fast bacteria forming irregular branching 
colonies on agar, including Nocardia cyriacigeorgica, 
Nocardia farcinica, Nocardia brasiliensis and 
Nocardia otitidiscaviarum, and other Nocardia species. 
N. paucivorans is a recently described species, 
identified by biochemical characteristics and 16S 
rDNA sequence analysis in bronchial secretions of a 
patient with chronic lung disease.
4,5
 
Human nocardiosis is usually recognized as a 
sporadic, community-acquired infection.
6
 Human 
nocardiosis affects both immunocompromised and 
immunocompetent hosts. Within the 
immunocompromising conditions, nocardiosis seems to 
affect primarily intravenous drug abusers, patients on 
systemic corticosteroids, AIDS patients, recipients of 
solid organ and bone marrow transplants, patients 
affected by chronic granulomatous diseases and 
hematologic malignancies. Host resistance to nocardial 
infection depends on cell-mediated immunity. Infection 
mainly occurs through direct skin inoculation or 
inhalation, and possible clinical manifestations are 
pulmonary nocardiosis, cutaneous and subcutaneous 
nocardiosis and systemic nocardiosis, including central 
nervous system (CNS) dissemination.
7-8
 CNS 
nocardiosis can be the result of prior pulmonary 
infection or can exist on its own. A recent literature 
review on the nocardiosis reported that CNS 
involvement can manifest mainly as cerebral abscesses 
but also as meningitis or both brain abscess and 
meningitis.
9
 The major species reported among the 
patients in this literature review were Nocardia 
asteroides (35%), N. farcinica (19%), and N. 
cyriacigeorgica (6%), even if Nocardia nomenclature 
dramatically changed in the last years complicating all 
etiological consideration.  Other less common species 
included Nocardia transvalensis (4%), N. brasilensis 
(3.6%), and N. otitidiscaviarum (2%) and others. Our 
patient had CNS nocardiosis due to  N. paucivorans. 
The largest series of N. paucivorans infections 
published to date included 33 cases collected in 
northeast Australia over a 20-years span, with 
dissemination in at least 33% of cases and CNS 
infection in 80% of disseminated cases. Therefore, it 
was hypothesized that N. paucivorans had an enhanced 
neurotropism.
10-11
 
Nocardial infection in multiple myeloma is quite a 
sporadic finding, often linked as a complication of 
bone marrow transplants.
12
 There is limited literature 
on nocardiosis in multiple myeloma patients that did 
not undergo bone marrow transplant, and there are still 
fewer cases of nocardial infections that occurred during 
novel anti-myeloma treatments. For instance, it was 
recently reported cases of brain abscesses by N. 
cyriacigeorgica in two patients treated with 
bortezomib.
13
 A PubMed search, crossing “Nocardia 
paucivorans” and “myeloma”, revealed no cases, and 
the N. paucivorans infections published so far in 
English literature did not occur in multiple myeloma 
patients.
10-11,13-15
 Therefore, to the best of our 
knowledge, the present case is the first infection due to 
N. paucivorans in a patient affected by multiple 
myeloma.  
Our patient had multiple risk factors for nocardiosis. 
The myeloma-related immunodeficiency includes 
mainly B cell dysfunction and cellular 
immunodeficiency
12,16
 with significantly reduced 
numbers of NK and T cells and impaired T cells 
function.
17
 Lenalidomide is a synthetic derivative of 
thalidomide, used in multiple myeloma for its 
immunomodulatory properties. The molecule induces a 
IL-2-mediated primary T cell proliferation with a 
concomitant increase in IFN-γ production along with 
anti-angiogenic, anti-proliferative, and pro-apoptotic 
properties.
18
 However, lenalidomide combination 
therapy has shown to be prone to an increased risk of 
infections. In fact, a meta-analysis of efficacy and 
safety of lenalidomide for multiple myeloma showed 
an increased risk of infections comparing lenalidomide 
regimen versus placebo (RR = 1.98; 95% CI: 1.50 to 
2.62).
19
 Therefore, an antibiotic prophylaxis should be 
considered as part of the treatment regimen.
19
 
Bortezomib induces apoptosis preferentially in rapidly 
proliferating and neoplastic cells via inhibition of NF-
κB activation. However, proteasome inhibition could 
influence the antigen processing and cytotoxic T-cell 
response and suppress essential immune functions of 
human CD4+ T cells. It has been shown that 
bortezomib therapy could increase the rate of 
opportunistic infectious complications, mainly within 
eight cycles of treatment during severe 
lymphocytopenia treatment-induced periods.
13,20
 
Corticosteroid therapy is widely associated with 
nocardial infections. Dexamethasone-based regimens 
in multiple myeloma increase the rate of bacterial 
infections (mainly encapsulated bacteria such as 
Staphylococcus aureus, and others including 
Enterobacteriaceae, Pseudomonas aeruginosa, 
mycobacteria), viral and micotic infections.
21
 An 
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observational study of 13 patients collected over a 13-
years period in two Spanish institutions showed that 
the most common risk factor for both pulmonary and 
disseminated nocardiosis was corticosteroid therapy 
(64% in the whole group of patients, 45.5% in 
disseminated nocardiosis patients).
22
 Dose and duration 
of steroid treatment in nocardiosis patients receiving 
corticosteroids prior to diagnosis varied widely in that 
study ranging from prednisone 40 mg/day for 15 days 
to prednisone 7.5 mg/day for 13 years.  
Our patient received for the nocardiosis a 
combination regimen of TMP-SMX plus meropenem 
that was switched to a long term oral therapy with 
ciprofloxacin. Optimal antimicrobial treatment 
regimens have not been firmly established for 
nocardiosis, and the management of the disease must 
be individualized. Immunosuppressed patients and 
those with CNS disease should receive at least 12 
months of antimicrobial therapy with the appropriate 
clinical monitoring .
7
 In CNS nocardiosis, the antibiotic 
regimen should include drugs with a favorable CNS 
penetration, as the ones we used for our patients. 
In conclusion, this is the first report of multiple 
brain abscesses caused by N. paucivorans in a patient 
suffering from multiple myeloma. In this patient the 
risk factors for a nocardial infection included the  
hematological disease and chemotherapy.  Among the 
various chemotherapy regimens, we suggest that 
corticosteroids and lenalidomide had a pivotal role as 
risk factors for nocardiosis in the present case. 
Although nocardial infection itself in multiple 
myeloma is an uncommon infectious complication so 
far,
13
 nocardial brain abscesses should be added to the 
spectrum of adverse effect due to the novel anti-
myeloma drugs. We emphasize the importance in 
nocardial infections of obtaining the species 
identification and the strain susceptibility in order to 
guide the long term antibiotic therapy. 
Finally, in our case etiological diagnosis was made 
possible by culture of brain biopsy. Other than the 
nocardial infection, the causes of focal brain infections 
in hematologic malignancies  could include for 
instance neurotoxoplasmosis, zygomycosis, 
aspergillosis, fusariosis.
23
 Given the risks of 
misdiagnosis or delayed diagnosis, we highlight the 
importance of such invasive procedure,  as a brain 
biopsy, to obtain samples for microbiological analysis 
in all cases of focal brain lesions, especially in the 
immunocompromised host.  
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